Prostate specific antigen (PSA) in breast and ovarian cancer

Anticancer Research

Volumn 17, Issue 6 D, 1997, Pages 4735-4737

  Kucera, E ^a,b   Kainz, C ^a   Tempfer, C ^a   Zeillinger, R ^a   Koelbl, H ^a   Sliutz, G ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Breast cancer; Ovarian cancer; Prognosis; Prostate specific antigen; Steroid hormone receptors

Indexed keywords

ESTROGEN RECEPTOR; PROSTATE SPECIFIC ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CHEMOLUMINESCENCE; CLINICAL ARTICLE; CYTOSOL; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOASSAY; LYMPH NODE METASTASIS; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS; PROSTATE ADENOCARCINOMA; TUMOR DIFFERENTIATION;

ADENOCARCINOMA; BREAST NEOPLASMS; CHEMILUMINESCENT MEASUREMENTS; CYTOSOL; FEMALE; HUMANS; IMMUNOASSAY; MALE; NEOPLASM STAGING; OVARIAN NEOPLASMS; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 0031418818     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Armbruster DA: Prostate-specific antigen: biochemistry, analytical methods, and clinical application (see comments). Clin Chem 39: 181-195, 1993.
2. Graves HC, Wehner N, Stamey TA: Ultrasensitive radioimmunoassay of prostate-specific antigen. Clin Chem 38: 735-742, 1992.
3. Levesque M, Hu H, D'Costa M, Diamandis EP: Prostate-specific antigen expression by various tumors. J Clin Lab Anal 9: 123-128, 1995.
4. Ossterling JE: Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol 145: 907-923, 1991.
5. Semjonow A, Brandt B, Oberpenning F, Hertle L: Different determination methods make interpretation of prostate-specific antigen more difficult. Urologe A 34: 303-315, 1995.
6. Wernert N, Albrech M, Sesterhenn I, Goebbels R, Bonkhoff H, Seitz G, Inniger R, Remberger K: The 'female prostate': location, morphology, immunohistochemical characteristics and significance. Eur Urol 22: 64-69, 1992.
7. Wu JT, Zhang P, Astill ME, Wilson LW, Lyons BW, Wu LL, Stephenson R: PSA immunoreactivity detected in LNCaP cell medium, breast tumor cytosol, and female serum. J Clin Lab Anal 9: 243-251, 1995.
8. Yu H, Diamandis EP: Ultrasensitive time-resolved immunofluorometric assay of prostate-specific antigen in serum and preliminary clinical studies. Clin Chem 39: 2108-2114, 1993.
9. Yu H, Diamandis EP: Prostate-specific antigen in milk of lactating women. Clin Chem 41: 54-58, 1995.
10. Yu H, Diamandis EP: Measurement of serum prostate specific antigen levels in women and in prostatectomized men with an ultrasensitive immunoassay technique. J Urol 153: 1004-1008, 1995.
11. Yu H, Diamandis EP, Levesque M, Asa SL, Monne M, Croce CM: Expression of the prostate-specific antigen gene by a primary ovarian carcinoma. Cancer Res 55: 1603-1606, 1995.
12. Yu H, Diamandis EP, Sutherland DJ: Immunoreactive prostate-specific antigen levels in female and male breast tumors and its association with steroid hormone receptors and patient age. Clin Biochem 27: 75-79, 1994.
13. Yu H, Diamandis EP, Monne M, Croce CM: Oral contraceptive-induced expression of prostate-specific antigen in the female breast. J Biol Chem 270: 6615-6618, 1995.
14. Yu H, Diamandis EP, Zarghami N, Grass L: Induction of prostate specific antigen production by steroids and tamoxifen in breast cancer cell lines. Breast Cancer Res Treat 32: 291-300, 1994.
15. Yu H, Giai M, Diamandis EP, Katsaros D, Sutherland DJ, Levesque MA, Roagna R, Ponzone R, Sismondi P: Prostate-specific antigen is a new favorable prognostic indicator for women with breast cancer. Cancer Res 55: 2104-2110, 1995.
16. Yu HE, Diamandis EP, Levesque M, Giai M, Roagna R, Ponzone R, Sismondi P, Monne M, Croce CM: Prostate specific antigen in breast cancer, benign breast diasease an normal breast tissue. Breast Cancer Res Treat 40: 171-178, 1996.